MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia

Nucleic Acids Research

Volumn 40, Issue 12, 2012, Pages 5201-5214

  Ye, Huashan ^a   Liu, Xiaowen ^a   Lv, Meng ^b   Wu, Yuliang ^a   Kuang, Shuzhen ^a   Gong, Jing ^a   Yuan, Ping ^a   Zhong, Zhaodong ^b   Li, Qiubai ^b   Jia, Haibo ^a   Sun, Jun ^a   Chen, Zhichao ^b   Guo, An Yuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 17; MICRORNA 19; MICRORNA 20A; MICRORNA 92A1; RNA; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BCL2L11 GENE; CARCINOGENESIS; CONTROLLED STUDY; CYLD GENE; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; HOXA9 GENE; HUMAN; HUMAN CELL; MOLECULAR PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA ANALYSIS; RUNX1 GENE; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; TRANSCRIPTION REGULATION; UPREGULATION;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HEK293 CELLS; HUMANS; MICRORNAS; NF-KAPPA B; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84863227351     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks175     Document Type: Article

References (69)

1. Pui,C.H., Relling,M.V. and Downing,J.R. (2004) Acute lymphoblastic leukemia. N. Engl. J. Med., 350, 1535-1548.
2. Hagemeijer,A. and Graux,C. (2010) ABL1 rearrangements in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer, 49, 299-308.
3. Goldberg,J.M., Silverman,L.B., Levy,D.E., Dalton,V.K., Gelber,R.D., Lehmann,L., Cohen,H.J., Sallan,S.E. and Asselin,B.L. (2003) Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J. Clin. Oncol., 21, 3616-3622. (Pubitemid 46594054)
4. Coustan-Smith,E., Mullighan,C.G., Onciu,M., Behm,F.G., Raimondi,S.C., Pei,D., Cheng,C., Su,X., Rubnitz,J.E., Basso,G. et al. (2009) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol., 10, 147-156.
5. Staal,F.J., van Dongen,J.J. and Langerak,A.W. (2007) Novel insights into the development of T-cell acute lymphoblastic leukemia. Curr. Hematol. Malig. Rep., 2, 176-182. (Pubitemid 47235568)
6. Teitell,M.A. and Pandolfi,P.P. (2009) Molecular genetics of acute lymphoblastic leukemia. Annu. Rev. Pathol., 4, 175-198.
7. Van Vlierberghe,P., Pieters,R., Beverloo,H.B. and Meijerink,J.P. (2008) Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Br. J. Haematol., 143, 153-168.
8. Ambros,V. (2004) The functions of animal microRNAs. Nature, 431, 350-355.
9. Calin,G.A. and Croce,C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866. (Pubitemid 44629897)
10. Schotte,D., Chau,J.C., Sylvester,G., Liu,G., Chen,C., van der Velden,V.H., Broekhuis,M.J., Peters,T.C., Pieters,R. and den Boer,M.L. (2009) Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia, 23, 313-322.
11. Lu,M., Zhang,Q., Deng,M., Miao,J., Guo,Y., Gao,W. and Cui,Q. (2008) An analysis of human microRNA and disease associations. PLoS One, 3, e3420.
12. Bousquet,M., Harris,M.H., Zhou,B. and Lodish,H.F. (2010) MicroRNA miR-125b causes leukemia. Proc. Natl. Acad. Sci. USA, 107, 21558-21563.
13. Schotte,D., Lange-Turenhout,E.A., Stumpel,D.J., Stam,R.W., Buijs-Gladdines,J.G., Meijerink,J.P., Pieters,R. and Den Boer,M.L. (2010) Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. Haematologica, 95, 1675-1682.
14. Fulci,V., Colombo,T., Chiaretti,S., Messina,M., Citarella,F., Tavolaro,S., Guarini,A., Foá,R. and Macino,G. (2009) Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Genes Chromosomes Cancer, 48, 1069-1082.
15. Zanette,D.L., Rivadavia,F., Molfetta,G.A., Barbuzano,F.G., Proto-Siqueira,R., Silva,W.A. Jr, Falcão,R.P. and Zago,M.A. (2007) miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz. J. Med. Biol. Res., 40, 1435-1440.
16. Mavrakis,K.J., Wolfe,A.L., Oricchio,E., Palomero,T., de Keersmaecker,K., McJunkin,K., Zuber,J., James,T., Khan,A.A., Leslie,C.S. et al. (2010) Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat. Cell Biol., 12, 372-379.
17. Nagel,S., Venturini,L., Przybylski,G.K., Grabarczyk,P., Schmidt,C.A., Meyer,C., Drexler,H.G., Macleod,R.A. and Scherr,M. (2009) Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. Leuk Lymph., 50, 101-108.
18. Li,X., Sanda,T., Look,A.T., Novina,C.D. and von Boehmer,H. (2011) Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL. J. Exp. Med., 208, 663-675.
19. Tsang,J., Zhu,J. and van Oudenaarden,A. (2007) MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol. Cell, 26, 753-767. (Pubitemid 46856248)
20. Shalgi,R., Lieber,D., Oren,M. and Pilpel,Y. (2007) Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput. Biol., 3, e131.
21. Re,A., Corá,D., Taverna,D. and Caselle,M. (2009) Genome-wide survey of microRNA-transcription factor feed-forward regulatory circuits in human. Mol. Biosyst., 5, 854-867.
22. Kim,J., Inoue,K., Ishii,J., Vanti,W.B., Voronov,S.V., Murchison,E., Hannon,G. and Abeliovich,A. (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science, 317, 1220-1224.
23. Yu,Z., Wang,C., Wang,M., Li,Z., Casimiro,M.C., Liu,M., Wu,K., Whittle,J., Ju,X., Hyslop,T. et al. (2008) A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell. Biol., 182, 509-517.
24. Brosh,R., Shalgi,R., Liran,A., Landan,G., Korotayev,K., Nguyen,G.H., Enerly,E., Johnsen,H., Buganim,Y., Solomon,H. et al. (2008) p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol. Syst. Biol., 4, 229.
25. Friard,O., Re,A., Taverna,D., De Bortoli,M. and Cora,D. (2010) CircuitsDB: a database of mixed microRNA/transcription factor feed-forward regulatory circuits in human and mouse. BMC Bioinform., 11, 435.
26. Wang,J., Lu,M., Qiu,C. and Cui,Q. (2010) TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res., 38, D119-D12
27. Guo,A.Y., Sun,J., Jia,P. and Zhao,Z. (2010) A novel microRNA and transcription factor mediated regulatory network in schizophrenia. BMC Syst. Biol., 4, 10.
28. Landgraf,P., Rusu,M., Sheridan,R., Sewer,A., Iovino,N., Aravin,A., Pfeffer,S., Rice,A., Kamphorst,A.O., Landthaler,M. et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401-1414. (Pubitemid 46970709)
29. Liang,Y., Ridzon,D., Wong,L. and Chen,C. (2007) Characterization of microRNA expression profiles in normal human tissues. BMC Genom., 8, 166.
30. Griffiths-Jones,S., Saini,H.K., van Dongen,S. and Enright,A.J. (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res., 36, D154-D158. (Pubitemid 351149713)
31. Sethupathy,P., Corda,B. and Hatzigeorgiou,A.G. (2006) TarBase: a comprehensive database of experimentally supported animal microRNA targets. RNA, 12, 192-197. (Pubitemid 43121923)
32. Jiang,Q., Wang,Y., Hao,Y., Juan,L., Teng,M., Zhang,X., Li,M., Wang,G. and Liu,Y. (2009) miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res., 37, D98-D104.
33. Betel,D., Wilson,M., Gabow,A., Marks,D.S. and Sander,C. (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res., 36, D149-D153. (Pubitemid 351149712)
34. Lewis,B.P., Burge,C.B. and Bartel,D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20. (Pubitemid 40094598)
35. Fujita,P.A., Rhead,B., Zweig,A.S., Hinrichs,A.S., Karolchik,D., Cline,M.S., Goldman,M., Barber,G.P., Clawson,H., Coelho,A. et al. (2010) The UCSC Genome Browser database: update 2011. Nucleic Acids Res., 39, D876-882.
36. Shannon,P., Markiel,A., Ozier,O., Baliga,N.S., Wang,J.T., Ramage,D., Amin,N., Schwikowski,B. and Ideker,T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res., 13, 2498-2504. (Pubitemid 37428274)
37. Huang da,W., Sherman,B.T. and Lempicki,R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
38. Livak,K.J. and Schmittgen,T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408. (Pubitemid 34164012)
39. Zhao,H., Wang,D., Du,W., Gu,D. and Yang,R. (2010) MicroRNA and leukemia: tiny molecule, great function. Crit. Rev. Oncol. Hematol., 74, 149-155.
40. Landais,S., Landry,S., Legault,P. and Rassart,E. (2007) Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res., 67, 5699-5707. (Pubitemid 46985002)
41. Subramanian,A., Tamayo,P., Mootha,V.K., Mukherjee,S., Ebert,B.L., Gillette,M.A., Paulovich,A., Pomeroy,S.L., Golub,T.R., Lander,E.S. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA, 102, 15545-15550. (Pubitemid 41528093)
42. O'Donnell,K.A., Wentzel,E.A., Zeller,K.I., Dang,C.V. and Mendell,J.T. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-843. (Pubitemid 40839736)
43. Sun,S.C. (2010) CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ., 17, 25-34.
44. Lappas,M., Permezel,M., Georgiou,H.M. and Rice,G.E. (2002) Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol. Reprod., 67, 668-673. (Pubitemid 34803959)
45. Vilimas,T., Mascarenhas,J., Palomero,T., Mandal,M., Buonamici,S., Meng,F., Thompson,B., Spaulding,C., Macaroun,S., Alegre,M.L. et al. (2007) Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat. Med., 13, 70-77. (Pubitemid 46067388)
46. Palomero,T., Dominguez,M. and Ferrando,A.A. (2008) The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia. Cell Cycle, 7, 965-970. (Pubitemid 351679827)
47. Sharma,V.M., Draheim,K.M. and Kelliher,M.A. (2007) The Notch1/c-Myc pathway in T cell leukemia. Cell Cycle, 6, 927-930. (Pubitemid 46658747)
48. Medyouf,H. and Ghysdael,J. (2008) The calcineurin/NFAT signaling pathway: a novel therapeutic target in leukemia and solid tumors. Cell Cycle, 7, 297-303. (Pubitemid 351366491)
49. Leung,K.T., Li,K.K., Sun,S.S., Chan,P.K., Ooi,V.E. and Chiu,L.C. (2008) Activation of the JNK pathway promotes phosphorylation and degradation of BimEL - a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia. Carcinogenesis, 29, 544-551. (Pubitemid 351404870)
50. Wong,P., Iwasaki,M., Somervaille,T.C., Ficara,F., Carico,C., Arnold,C., Chen,C.Z. and Cleary,M.L. (2010) The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. Cancer Res., 70, 3833-3842.
51. Mi,S., Li,Z., Chen,P., He,C., Cao,D., Elkahloun,A., Lu,J., Pelloso,L.A., Wunderlich,M., Huang,H. et al. (2009) Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc. Natl. Acad. Sci. USA, 107, 3710-3715.
52. Sasaki,K., Kohanbash,G., Hoji,A., Ueda,R., McDonald,H.A., Reinhart,T.A., Martinson,J., Lotze,M.T., Marincola,F.M., Wang,E. et al. (2010) miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy. J. Transl. Med., 8, 17.
53. Mu,P., Han,Y.C., Betel,D., Yao,E., Squatrito,M., Ogrodowski,P., de Stanchina,E., D'Andrea,A., Sander,C. and Ventura,A. (2009) Genetic dissection of the miR-17-92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev., 23, 2806-2811.
54. Ventura,A., Young,A.G., Winslow,M.M., Lintault,L., Meissner,A., Erkeland,S.J., Newman,J., Bronson,R.T., Crowley,D., Stone,J.R. et al. (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell, 132, 875-886. (Pubitemid 351312807)
55. Olive,V., Bennett,M.J., Walker,J.C., Ma,C., Jiang,I., Cordon-Cardo,C., Li,Q.J., Lowe,S.W., Hannon,G.J. and He,L. (2009) miR-19 is a key oncogenic component of mir-17-92. Genes Dev., 23, 2839-2849.
56. Chalhoub,N. and Baker,S.J. (2009) PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol., 4, 127-150.
57. Renner,O., Blanco-Aparicio,C. and Carnero,A. (2008) Genetic modelling of the PTEN/AKT pathway in cancer research. Clin. Transl. Oncol., 10, 618-627.
58. Silva,A., Yunes,J.A., Cardoso,B.A., Martins,L.R., Jotta,P.Y., Abecasis,M., Nowill,A.E., Leslie,N.R., Cardoso,A.A. and Barata,J.T. (2008) PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J. Clin. Invest., 118, 3762-3774.
59. Gutierrez,A., Sanda,T., Grebliunaite,R., Carracedo,A., Salmena,L., Ahn,Y., Dahlberg,S., Neuberg,D., Moreau,L.A., Winter,S.S. et al. (2009) High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood, 114, 647-650.
60. Dorsam,S.T., Ferrell,C.M., Dorsam,G.P., Derynck,M.K., Vijapurkar,U., Khodabakhsh,D., Pau,B., Bernstein,H., Haqq,C.M., Largman,C. et al. (2004) The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. Blood, 103, 1676-1684. (Pubitemid 38268959)
61. Hughes,P., Bouillet,P. and Strasser,A. (2006) Role of Bim and other Bcl-2 family members in autoimmune and degenerative diseases. Curr. Dir. Autoimmun., 9, 74-94.
62. Li,W.Q., Guszczynski,T., Hixon,J.A. and Durum,S.K. (2010) Interleukin-7 regulates Bim proapoptotic activity in peripheral T-cell survival. Mol. Cell. Biol., 30, 590-600.
63. Jiang,N., Koh,G.S., Lim,J.Y., Kham,S.K., Ariffin,H., Chew,F.T. and Yeoh,A.E. (2011) BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia. Exp. Hematol., 39, 321-329, 329 e1-e3.
64. Paganin,M. and Ferrando,A. (2011) Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. Blood Rev., 25, 83-90.
65. Courtois,G. (2008) Tumor suppressor CYLD: negative regulation of NF-kappaB signaling and more. Cell Mol. Life Sci., 65, 1123-1132.
66. Sun,S.C. (2011) Non-canonical NF-kappaB signaling pathway. Cell Res., 21, 71-85.
67. Molitoris,J.K., McColl,K.S. and Distelhorst,C.W. (2011) Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17-92 contributes to the induction of Bim and initiation of apoptosis. Mol. Endocrinol., 25, 409-420.
68. Zhao,Y.M., Zhou,Q., Xu,Y., Lai,X.Y. and Huang,H. (2008) Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition. Acta Pharmacol. Sin., 29, 481-488. (Pubitemid 351465508)
69. Avellino,R., Romano,S., Parasole,R., Bisogni,R., Lamberti,A., Poggi,V., Venuta,S. and Romano,M.F. (2005) Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood, 106, 1400-1406. (Pubitemid 41129607)